| 6/1/2016 | CV | Stewart Enterprises’ 3.375% senior notes convertible into cash June 15-July 14
|
| 6/17/2013 | BKCVHY | Moody's: Stewart outlook to negative
|
| 6/10/2013 | BKCVHY | S&P ups Stewart Enterprises
|
| 5/30/2013 | BKCVHY | S&P puts Stewart on developing watch
|
| 5/30/2013 | BKCVHYIG | Moody's could cut Service, Stewart
|
| 12/16/2011 | BKCVHY | Stewart Enterprises operating cash flow rises to $87 million in 2011
|
| 4/6/2011 | BKCVHY | S&P cuts Stewart convertibles
|
| 4/4/2011 | BKCVHY | Moody's: Stewart notes at B1
|
| 4/4/2011 | BKCVHY | S&P rates Stewart notes BB-
|
| 3/23/2011 | BKCVHY | S&P ups Stewart
|
| 9/9/2010 | BKBWCVHY | Stewart Enterprises may buy back more debt if returns call for it: CFO
|
| 9/8/2010 | CVLM | Stewart Enterprises reports purchase of $14.9 million of convertibles
|
| 6/8/2010 | CVLM | Stewart Enterprises reports repurchase of $6 million of convertibles
|
| 12/18/2009 | BKBWCVHY | Stewart Enterprises intends to pursue growth through acquisitions
|
| 9/10/2009 | CV | Stewart Enterprises repurchases $35.7 million senior convertibles
|
| 6/15/2009 | BKCVHY | Moody's affirms Stewart
|
| 6/9/2009 | CV | Stewart Enterprises buys back $40.1 million senior convertible notes
|
| 12/19/2008 | BKBWCVHY | Stewart Enterprises says debt and stock repurchases, acquisitions possible in 2009
|
| 6/22/2007 | CV | Market Commentary: Stewart flat, Dollar Financial gains slightly, NovaMed quiet on dull debuts; PrivateBancorp falls with stock
|
| 6/22/2007 | CV | New Issue: Stewart sells $250 million convertibles; 7 years at 3.125%, 9 years at 3.375%, all up 32.5%
|
| 6/21/2007 | BKCVHY | S&P cuts Stewart Enterprises, gives convertibles BB-
|
| 6/21/2007 | BKCVHY | Moody's rates Stewart convertibles Ba3
|
| 6/21/2007 | CV | Market Commentary: Archstone-Smith slips on sector concerns; Dollar Financial, NovaMed, Stewart quiet in gray
|
| 6/20/2007 | CV | Stewart talks $250 million convertibles; seven-years at 2.875%-3.375%, nine-years at 3.125%-3.625%, all up 30%-35%
|
| 6/20/2007 | CV | Market Commentary: CVRD gains early; Encysive firmer; Panda delays deal; Stewart, Dollar Financial, NovaMed plan deals
|
